Mad Money with Jim Cramer

» more from Mad Money with Jim Cramer

Pfizer (PFE)

Cramer was not a Pfizer fan prior to its purchase of Wyeth, but he praised the deal’s $4 billion in cost savings and the boost it gave to Pfizer's pipeline and product portfolio. PFE now yields 3.8% thanks to a recent dividend increase to 18 cents a share from 16 cents, and Cramer expects a whopping $46 billion to be returned to shareholders between 2010 and 2015. And, like all of the Mad Money host’s dividend picks, Pfizer has plenty of cash on hand to cover that payout.